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Candida albicansand Candida dubliniensis are highly related pathogenic yeast species. However, C. albicans is far more prevalent in
human infection and has been shown to be more pathogenic in a wide range of infection models. Comparison of the genomes of
the two species has revealed that they are very similar although there are some signiﬁcant diﬀerences, largely due to the expansion
of virulence-related gene families (e.g., ALS and SAP)i nC. albicans, and increased levels of pseudogenisation in C. dubliniensis.
Comparative global gene expression analyses have also been used to investigate diﬀerences in the ability of the two species to
tolerateenvironmental stressandtoproduce hyphae, twotraitsthatare likely toplay aroleinthelower virulence of C.dubliniensis.
Taken together, these data suggest that C. dubliniensis is in the process of undergoing reductive evolution and may have become
adapted for growth in a specialized anatomic niche.
1.Introduction
Fungi are an important cause of human infection, and yeast
species of the genus Candida are the most pathogenic fungi.
While most Candida species are found in the environment,
approximately a dozen or so are associated with colonization
and infection of humans [1]. Candida species are common
commensals of the oral cavity, intestinal tract and vagina,
with newborns being colonized soon after birth. While these




systemic infections that can spread via the bloodstream to
organs throughout the body. The risk factors for candidal
vaginitis are poorly understood; however, other candidal
infections are largely the result of host-related defects.
These include depletion of CD4 T cells in HIV-infected
individuals, which predisposes to oropharyngeal candidosis,
or neutropenia and intestinal surgery, both of which are
signiﬁcant risk factors for systemic infection [1–3].
Candida albicans is widely recognized as being the
most pathogenic yeast species and in the majority of
epidemiological studies has been found to be the most
common cause of superﬁcial and systemic infections. Other
species, such as Candida glabrata, Candida parapsilosis,
and Candida tropicalis have also been associated with
most forms of candidiasis and the relative distribution of
each species can vary depending on geographic location,
patient cohort, and previous exposure to antifungal drugs
[2, 4]. In 1995, a new Candida species was identiﬁed in
HIV-infected individuals with oropharyngeal candidosis in
Dublin, Ireland [5]. This species, which was subsequently
named Candida dubliniensis, is very closely related to C.
albicans with which it shares many phenotypic properties,
includingtheabilitytoproducehyphaeandchlamydospores,
traits previously speciﬁcally associated only with C. albicans
[6–8]. Phylogenetic studies indicate that C. dubliniensis is
the species that is most closely related to C. albicans,a n d
it is often quite diﬃcult to discriminate between the two
species in clinical samples [9, 10]. Indeed it was only when
DNA ﬁngerprinting techniques were applied to the large-
scale analysis of C. albicans populations in epidemiological
studies that the ﬁrst isolates of C. dubliniensis were originally
identiﬁed [5]. Surprisingly, despite the close phylogenetic
relationship of the two species epidemiological data show
that C. albicans is far more prevalent than C. dubliniensis.I n
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is found in >50% of cases, while if it is identiﬁed at all,
C. dubliniensis has only been found in at most 2-3% of
cases [11–13]. This apparent discrepancy between the ability
of the two species to cause infection is also reﬂected in
data obtained from comparative studies in a wide range of
infection models (e.g., systemic and mucosal) which clearly
show that C. albicans is signiﬁcantly more pathogenic than
C. dubliniensis [10, 14–18].
The identiﬁcation of virulence-associated factors in
Candida species is complicated by the fact that they are
opportunistic pathogens that usually exist in harmony with
the human host as part of the commensal ﬂora and only
cause infection when host deﬁciencies permit. Since it is by
far the most pathogenic Candida species, C. albicans is the
best-studied member of the genus in terms of pathogenesis.
The most commonly cited C. albicans virulence factors
include adhesins (e.g., Hwp1 [19] and the Als family [20]),
extracellular enzymes (e.g., the secreted aspartyl proteinase
(Sap) family [21] and phospholipases [22]), and most
importantly of all, the ability to alternate between unicellular
yeast and ﬁlamentous hyphal forms of growth [23]. Both
morphological forms have been shown to be essential for
virulence. Hyphae have been proposed to play a major role
in adhesion, invasion, and bioﬁlm formation while yeast
cells are likely to be important for dissemination and initial
colonization of host surfaces [24]. Comparative phenotypic
analysis of C. albicans and C. dubliniensis has suggested that
in vitro isolates of C. dubliniensis exhibit higher levels of
proteinase activity, are more adherent to buccal epithelial
cells, and undergo phenotypic switching at a higher rate than
C. albicans [10, 25–27]. In addition, as described earlier,
C. dubliniensis is the only Candida species, other than C.
albicans t h a ti sa b l et op r o d u c eh yp h a e[ 5, 6]. Given the close
relationship between the two species and the fact that they
are so alike phenotypically, at ﬁrst glance, it is diﬃcult to
understand why there is such disparity in the capacity of
C. albicans and C. dubliniensis to colonise and cause disease
in humans. This short review appraises recent ﬁndings that
help to clarify this conundrum and explain how C. albicans
appears to have evolved to be a better commensal and
opportunistic pathogen than C. dubliniensis.
2. ComparativeGenomicAnalysisof
C. albicans and C. dubliniensis
The C. albicans genome sequence was ﬁrst published in
2004 [28], with improved annotation and analysis subse-
quently reported in 2005 [29] and 2007 [30]. In an early
attempt to identify genomic diﬀerences that might serve to
explain the disparity in the virulence of C. albicans and
C. dubliniensis, Moran et al. cohybridized genomic DNA
from each species to C. albicans w h o l eg e n o m em i c r o a r r a y s
to identify genes that are only present in C. albicans [31].
This relatively crude experiment suggested that there are
247 (approx. 4%) C. albicans genes that are either absent or
highly (i.e., >60%) divergent in the C. dubliniensis genome.
Interestingly, several genes strongly associated with C. albi-
cans virulence are included in the list of absent/divergent
genes. In 2009, in order to further investigate the genetic
diﬀerences between the two species the Wellcome Trust
Sanger Institute sequenced the entire C. dubliniensis genome
[32]. Comparison of the two genome sequences revealed
that, despite major karyotypic diﬀerences, the genomes of
the two species are remarkably similar with 96.3% of genes
exhibiting >80% identity, while 98% of genes are syntenic,
thus,conﬁrmingtheveryclosephylogeneticrelationshipand
the relatively recent divergence of the two species (estimated
to have occurred approx. 20 million years ago [33]).
When transposable elements were discounted, comparison
of the two genome sequences revealed that there are 29
C. dubliniensis-speciﬁc genes and 168 C. albicans-speciﬁc
genes. The majority of the diﬀerences observed between the
two species can be accounted for by the expansion of gene
families in C. albicans, many of which have been previously
associated with virulence. In particular, genes missing from
the C. dubliniensis genome include those encoding hypha-
speciﬁc virulence factors, such as the cell surface proteins
Hyr1 and Als3 and two members of the secreted aspartyl
proteinase family (i.e., Sap5 and Sap6), while the gene
encoding the well-characterized epithelial adhesin Hwp1 is
highly divergent [31, 32]. Hyr1 has been shown to confer
resistance to neutrophil killing activity [34] and, along with
Hwp1, has been shown recently to play an important role in
oral mucosal bioﬁlm formation [35]. Als3 has been shown
to play an important role in adhesion to host cells and has
been shown to have invasin-like [36] and iron-sequestering
[37] activity, while the Saps are well-known virulence factors
[21]. The biggest diﬀerence in gene family size between the
two species is the TeLOmere-associated (TLO) family which
is comprised of 14 genes in C. albicans, but only two genes in
C. dubliniensis. Sequence comparisons suggest that the TLO
genes encode transcriptional regulators, and preliminary
analysis of the phenotype of C. dubliniensis Δtlo mutants
suggests that these genes may play a role in the control of
hypha formation [32]. In addition to these diﬀerences, a
range of genes appear to be in the process of being lost
by C. dubliniensis. There are 78 C. dubliniensis pseudogenes
with intact positional orthologs in C. albicans, including
genes identiﬁed as ﬁlamentous growth regulators (FGR) in
haploinsuﬃciency studies [38]. These ﬁndings suggest that
C. dubliniensis is undergoing a process of reductive evolution
leading to the loss of genes that have been associated with C.
albicans virulence. Interestingly, many of these genes are only
expressed by the hyphal form of growth and are likely to play
a prominent role in host-pathogen interaction.
One of the most prominent phenotypic diﬀerences
between C. albicans and C. dubliniensis is their diﬀerent
capacity to tolerate environmental stress, with the former
being far more tolerant of thermal, osmotic, and oxidative
stress [5, 14, 39, 40]. Indeed, comparative growth at 45◦Ci s
commonly used as a simple diagnostic test to discriminate
between the two species [41]. Comparative transcriptional
proﬁling analysis revealed that although the two species
express similar core stress responses, C. dubliniensis mounts
a more robust response to thermal stress and a very poor
transcriptional response to oxidative and osmotic stress [39].
Forward genetic screens using a C. albicans library to try
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dubliniensis to environmental stress failed to identify any
single gene that could complement oxidative and thermal
sensitivity, suggesting that these are likely to be polygenic
traits. However, the C. albicans ENA21 gene, which encodes a
sodium eﬄux pump, was found to increase the salt tolerance
of C. dubliniensis [39]. Since the C. dubliniensis ortholog of
this gene appears to be functional but not upregulated in
responsetothepresenceofsalt,itislikelythatthediﬀerential
saltstresssusceptibilityofthetwospeciesisduetodiﬀerences
in stress-related transcriptional regulatory pathways.
3.ComparativeAnalysisofHyphaFormationby
C. albicans and C. dubliniensis
One of the most important and best-studied virulence
factors of C. albicans is its ability to switch between yeast
and ﬁlamentous growth forms (i.e., dimorphism), a trait
also shared by C. dubliniensis [5]. However, although C.
dubliniensis is capable of producing germ tubes and true
hyphae, it does so far less eﬃciently than C. albicans, both
in vivo and under a wide range of in vitro conditions [16,
42, 43]. Given the perceived importance of dimorphism
in C. albicans virulence, we have previously suggested that
the lower virulence of C. dubliniensis may, at least in part,
be related to its relatively poor ability to switch between
yeast and hyphal forms [16]. Evidence in support of this
was obtained from murine systemic infection model studies
[14, 15] and the neonatal orogastric infection model [16]. In
the latter, stomach and kidney samples in infected animals
contained only C. dubliniensis yeast cells, while C. albicans
cells were found in both the yeast and hyphal forms [16].
WehaveusedtheRHEmodelofsuperﬁcialinfection[44]
to compare the invasive potential of both species (Figure 1).
In particular, in this model, C. albicans grows as both yeast
and hyphae and invades the tissue causing major damage.
In contrast, C. dubliniensis grows exclusively in the yeast
forminthismodel,therefore,causingrelativelylimitedtissue
invasion and damage [16, 17]. In order to investigate why
the two species diﬀer so markedly in virulence in this model
and in order to identify novel virulence-associated genes;
Spiering et al. compared their global gene expression proﬁles
during the early stages of RHE infection [17]. Both species
showed similar expression proﬁles for ribosomal and general
metabolicgenes,however,unsurprisingly,C.albicansshowed
increased expression of hypha-speciﬁc virulence genes (e.g.,
ECE1, HWP1, HYR1, and ALS3) within 30 minutes of
infection. In contrast, C. dubliniensis showed a far less robust
transcriptional response and no expression of hypha-speciﬁc
genes. In addition, several genes with unknown function
were found to be speciﬁcally upregulated in C. albicans that
are absent from or very divergent in the C. dubliniensis
genome. One of these genes, named SFL2 due to its sequence
similarity to the transcription factor-encoding gene SFL1,
encodes a putative DNA-binding heat shock factor protein.
When the gene was deleted in C. albicans, it resulted in the
failure to produce hyphae under a wide range of growth
conditions,includingtheRHEinfectionmodel.Interestingly,
the Δsﬂ2 mutation had no eﬀect on survival in the murine
systemic infection model, although histological analysis
revealed that the kidneys of infected mice were infected
only with yeast cells, while the kidneys of mice infected
with the wild-type parental strains contained both yeast and
predominantlyhyphalcells[17].Inasubsequentstudy,ithas
been shown that the Δsﬂ2 mutant exhibits reduced virulence
in a mouse model of gastrointestinal infection, suggesting
that Sﬂ2 is required for the penetration of the gut wall and
subsequent dissemination throughout the body [45]. The C.
dublinensis ortholog of SFL2 is only 50% identical and is not
expressed under the same conditions as the C. albicans gene,
therefore it is possible that the divergence of this gene and its
apparent lack of expression may be partly responsible for its
lower virulence.
Recent studies by our group have been directed towards
investigating the molecular basis for diﬀerences in the
signaling pathways responsible for ﬁlamentation in the
two species. Comparative genome analysis suggests that
orthologs of the known components of the major C. albi-
cans morphogenetic pathways (e.g., Cph1-mediated MAPK
and the Efg1-mediated Ras1-cAMP pathways) are highly
conserved in C. dubliniensis, so the reduced capacity of C.
dubliniensis to produce hyphae and express hypha-speciﬁc
genes such as SFL2 is unlikely to be due to the absence of
regulators involved in these pathways. Forced stimulation
of the Ras1-cAMP pathway with a hyperactive RAS1G113V
allele did not result in increased true hypha formation in
C. dubliniensis, suggesting strong repression of the RAS1-
cAMP pathway itself or downstream regulators [43]. One of
themostimportanttranscriptionalregulatorsinvolvedinthe
control of morphogenesis in C. albicans is Nrg1, which Staib
and Morschh¨ auser. showed that it is diﬀerentially expressed
by C. dubliniensis when grown on media such as Staib agar
[46]. In C. albicans this protein targets the negative regulator
Tup1 to speciﬁc sequences in the promoters of genes
involved in hypha formation. NRG1 expression is rapidly
downregulated in C. albicans cells incubated under hypha-
inducing conditions, including when cells are phagocytosed
by murine macrophages, which results in germination and
escape from the phagocytes. However, in C. dubliniensis,
NRG1 expression remains high under these conditions,
preventing hypha formation and causing cells to remain in
the yeast phase, which in the murine macrophage model
results in failure to escape from the phagocytes and the
death of the fungus [43]. Deletion of the NRG1 gene in
C. dubliniensis resulted in an increase in the rate of hypha
and particularly pseudohypha formation, which in turn led
to increased survival when exposed to murine macrophages
as well as increased virulence in the reconstituted human
epithelial (RHE) cell model of oral candidosis. Surprisingly,
the C. dubliniensis Δnrg1 mutant was no more virulent than
its parent strain in the murine systemic infection model and
formedmainlypseudohyphaeininfectedkidneys,suggesting
an additional level of repression preventing true hypha
formation in vivo [43].
Recent investigations by O’Connor et al. have suggested
thatrepressionofﬁlamentationin C.dubliniensisismediated
by nutrients. In order to improve our understanding of
how environmental signals trigger these pathways O’Connor4 International Journal of Microbiology
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Figure 1: Photomicrograph of C. albicans SC5314 and C. dubliniensis CD36 infecting oral reconstituted human epithelial (RHE) tissue. (a)
C. albicans originally grown in nutrient-rich YPD, note the presence of hyphae and extensive tissue invasion and damage; (b) C. dubliniensis
originally grown in YPD, note the absence of hyphae and the limited level of invasion and tissue damage; (c) C. dubliniensis originally grown
in Lee’s medium, note the increased level of ﬁlamentation and invasion. Scale bars, approximately 25µm.
et al. investigated the eﬀects of nutrient availability on the
rate of hypha formation [42]. One of the most common
incubation conditions for inducing hypha formation in C.
albicans is incubation in the nutrient-rich medium YPD
supplemented with 10% (vol/vol) fetal calf serum at 37◦C.
Under these conditions >80% of C. albicans cells produced
germ tubes/ﬁlaments within two hours, in contrast only
∼20% of C. dubliniensis cells were observed to produce
hyphae under the same induction conditions. However,
when C. dubliniensis cells were incubated in water supple-
mented with 10% (vol/vol) fetal calf serum (WS) at 37◦C,
the level of hypha producing cells increased to 90% (i.e.,
similar to the level of hypha formation by C. albicans),
suggesting that a nutrient-rich environment, in particular
the presence of complex mixtures of peptides, suppressed
hypha formation in this species. This was conﬁrmed when
the addition of peptone and peptone and glucose was found
to signiﬁcantly reduce the levels of hyphae, suggesting that
nutrient starvation is a prerequisite for hypha formation
by C. dubliniensis [42]. These morphological changes were
coupled with changes in the expression of genes encoding
key transcriptional regulators, such as NRG1 and UME6,
which were signiﬁcantly altered in WS, with the former
downregulated by 70% and the latter upregulated 30-
fold. Overexpression of the UME6 gene (which encodes a
protein required for hyphal extension), using a doxycycline-
inducible promoter led to C. dubliniensis cells being able
to produce true hyphae, even in nutrient-rich media such
as YPD. Similarly, preculture of C. dubliniensis cells in
nutrient poor media, such as Lee’s medium, pH 4.5, prior
to the induction of hyphae in YPDS also resulted in a
transient ability of C. dubliniensis cells to produce hyphae
which increased the ability of these cells to adhere to and
invade epithelial tissue in the RHE model (see Figure 1)
and increased survival in the murine macrophage infection
model [42].
These data suggest that factors controlling UME6 expres-
sion in C. dubliniensis are repressed by the presence of
nutrients, and unlike C. albicans, this repression cannot be
lifted by a shift to alkaline pH, which occurs when serum
is added to the medium. UME6 is likely to be regulated by
Efg1andEed1 andis thereforeunderthecontrolofthe Ras1-
cAMP pathway. Few studies have investigated how nutrients
regulate this pathway in C. albicans or C. dubliniensis.
Preliminary investigations in our laboratory have shown that
rapamycin, an inhibitor of the nutrient sensing kinase Tor1
(a kinase that plays a central role in the control of responses
to nutrient availability [47]), can stimulate transient hypha
formation in C. dubliniensis in nutrient-rich YPD serum
[48]. This derepression of hypha formation in the presence
of nutrients is concomitant with a reduction of NRG1 and
an increase in UME6 expression. These data suggest that
diﬀerences in Tor1 activity may play a role in the diﬀerential
ability of C. albicans and C. dubliniensis to form hyphae. TheInternational Journal of Microbiology 5
Table 1: Comparison of C. albicans and C. dubliniensis.
C. albicans C. dubliniensis References
Growth and morphology
Growth at ≥42◦CY e sN o [ 39, 41]
Growth in high salt media Yes No [39, 40]
Hypha formation in YPD + serum Yes Poor [16, 42]
Hypha formation in water + serum Yes Yes [42]
RHE infection model yeasts and hyphae yeasts only [17]
Genome
Chromosome number 8 9–11 chromosome-sized fragments [7]
No. of species-speciﬁc genes 168 29 [32]
ALS3 Present Absent [32]
HYR1 Present Absent [32]
SAP4, 5 and 6 All three genes One gene [32]
HWP1 Present Divergent [32]
TLO family 14 genes 2 genes [32]
molecular basis for the diﬀerence in the activity of Tor1 in
the two species is currently under investigation.
4. Conclusions
Candidal pathogenicity involves the complex interplay of
a wide range of virulence-associated factors. Comparative
analysis of C. albicans and C. dubliniensis genomic and
transcriptomic data has revealed that the reasons for the
diﬀerences in the capacity of these two species to cause
disease are also complex and are not due to a simple defect
in C. dubliniensis. Instead these studies have revealed genetic
diﬀerences in the two species, which, at least in part, may
explain the diﬀerences in their capacity to tolerate stress and
to ﬁlament. It is clear that the C. dubliniensis genome is
missing important virulence genes (e.g., ALS3 and HYR1),
is in the process of losing others (e.g., the FGR genes), has
failed to expand certain gene families (e.g., the SAP and TLO
families), and has undergone some degree of transcriptional
rewiring (e.g., the Tor pathway and Sﬂ2). All of these
diﬀerences suggest that the main discrepancy between these
two closely related species relates to diﬀerences in hypha
formation and the expression of hypha-speciﬁc products
(summarized in Table 1). We propose that C. dubliniensis is
in the process of undergoing reductive evolution, whereby
its genetic repertoire is diminishing in comparison with
C. albicans and their common ancestor. One of the main
phenotypic manifestations of this is the narrowing of
environmental conditions permissive for hypha formation,
perhaps as a result of specialization for survival in a speciﬁc
(as yet unidentiﬁed) anatomic niche where hyphae are not
required for colonization or growth. By further investigating
the molecular basis for the diﬀerences between C. albicans
and C. dubliniensis, we hope to improve our understanding
of candidal virulence, in particular the relative contribution
of hyphae and hypha-speciﬁc proteins to the pathogenesis of
candidal infections.
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